bromodeoxyuridine has been researched along with Carotid Stenosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afroze, T; Gros, R; Husain, M; Kalair, W; Mungrue, IN; Ravi, B; Sadi, AM; You, XM | 1 |
Foroudi, F; Lincoff, AM; Marso, SP; Park, SH; Topol, EJ; Zhou, Z | 1 |
2 other study(ies) available for bromodeoxyuridine and Carotid Stenosis
Article | Year |
---|---|
Conditional expression of a dominant-negative c-Myb in vascular smooth muscle cells inhibits arterial remodeling after injury.
Topics: Animals; Bromodeoxyuridine; Carotid Stenosis; Cell Division; Disease Models, Animal; Gene Expression; Genes, Dominant; Homeodomain Proteins; Mice; Mice, Transgenic; Microfilament Proteins; Muscle Proteins; Muscle, Smooth, Vascular; Promoter Regions, Genetic; Proto-Oncogene Proteins c-myb; Tetracycline; Transcription Factors; Tunica Intima | 2003 |
Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus.
Topics: Animals; Bromodeoxyuridine; Carotid Arteries; Carotid Stenosis; Catheterization; Cell Count; Cell Division; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Disease Progression; Hyperplasia; Immunohistochemistry; Male; Obesity; Rats; Rats, Sprague-Dawley; Rats, Zucker; Tunica Intima; Vascular Patency | 2001 |